Shafique Virani - Jun 2, 2021 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role: Chief Corp. Dev. Officer
Signature: /s/ Nathan Hatfield, attorney-in-fact
Stock symbol: RXRX
Transactions as of: Jun 2, 2021
Transactions value $: $100,000
Form type: 4
Date filed: 6/4/2021, 04:00 PM
Next filing: Feb 8, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXRX	Class A Common Stock	Options Exercise	$100K	+45K	+250.25%	$2.22^*	63K	Jun 2, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RXRX	Stock Option (Right to Buy)	Options Exercise	$0	-45K	-6.15%	$0.00	687K	Jun 2, 2021	Class A Common Stock	45K	$2.22	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.